59 related articles for article (PubMed ID: 30013686)
1. Characterisation of the cell and molecular biological effect of peptide-based daunorubicin conjugates developed for targeting pancreatic adenocarcinoma (PANC-1) cell line.
Szász Z; Enyedi KN; Takács A; Fekete N; Mező G; Kőhidai L; Lajkó E
Biomed Pharmacother; 2024 Apr; 173():116293. PubMed ID: 38430628
[TBL] [Abstract][Full Text] [Related]
2. Enhanced In Vitro Antitumor Activity of GnRH-III-Daunorubicin Bioconjugates Influenced by Sequence Modification.
Schuster S; Biri-Kovács B; Szeder B; Buday L; Gardi J; Szabó Z; Halmos G; Mező G
Pharmaceutics; 2018 Nov; 10(4):. PubMed ID: 30423956
[TBL] [Abstract][Full Text] [Related]
3. Targeting the Melanocortin 1 Receptor in Melanoma: Biological Activity of α-MSH-Peptide Conjugates.
Szabó I; Biri-Kovács B; Vári B; Ranđelović I; Vári-Mező D; Juhász É; Halmos G; Bősze S; Tóvári J; Mező G
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256168
[TBL] [Abstract][Full Text] [Related]
4. Hydrophilic Polyhedral Oligomeric Silsesquioxane, POSS(OH)
Piorecka K; Janaszewska A; Majkowska M; Marcinkowska M; Kurjata J; Kazmierski S; Radzikowska-Cieciura E; Kost B; Sowinski P; Klajnert-Maculewicz B; Stanczyk WA
Materials (Basel); 2020 Dec; 13(23):. PubMed ID: 33287168
[TBL] [Abstract][Full Text] [Related]
5. Thermodynamic and cellular studies of doxorubicin/daunorubicin loaded by a DNA tetrahedron for diagnostic imaging, chemotherapy, and gene therapy.
Li X; Wu Y; Zhang X; Liu J; Zhang Y; Yuan L; Liu M
Int J Biol Macromol; 2023 Nov; 251():126245. PubMed ID: 37562474
[TBL] [Abstract][Full Text] [Related]
6. Drug Conjugates for Targeting Eph Receptors in Glioblastoma.
Sharma P; Roberts C; Herpai D; Fokt ID; Priebe W; Debinski W
Pharmaceuticals (Basel); 2020 Apr; 13(4):. PubMed ID: 32340173
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Cytotoxicity Evaluation of Anticancer Drugs between Real-Time Cell Analysis and CCK-8 Method.
Cai L; Qin X; Xu Z; Song Y; Jiang H; Wu Y; Ruan H; Chen J
ACS Omega; 2019 Jul; 4(7):12036-12042. PubMed ID: 31460316
[TBL] [Abstract][Full Text] [Related]
8. Correction to "Development of Cytotoxic GW7604-Zeise's Salt Conjugates as Multitarget Compounds with Selectivity for Estrogen Receptor-Positive Tumor Cells".
Grabher P; Kapitza P; Hörmann N; Scherfler A; Hermann M; Zwerger M; Varbanov HP; Kircher B; Baecker D; Gust R
J Med Chem; 2024 May; 67(9):7663. PubMed ID: 38652527
[No Abstract] [Full Text] [Related]
9. Effect of vitamin B12 on methotrexate-induced cardiotoxicity in rats.
Kuloğlu N; Karabulut D; Kaymak E; Akin AT; Ceylan T; Yıldırım AB; Yakan B
Iran J Basic Med Sci; 2024; 27(6):733-739. PubMed ID: 38645491
[TBL] [Abstract][Full Text] [Related]
10. Oxime-Linked Peptide-Daunomycin Conjugates as Good Tools for Selection of Suitable Homing Devices in Targeted Tumor Therapy: An Overview.
Mező G; Gomena J; Ranđelović I; Dókus EL; Kiss K; Pethő L; Schuster S; Vári B; Vári-Mező D; Lajkó E; Polgár L; Kőhidai L; Tóvári J; Szabó I
Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339141
[TBL] [Abstract][Full Text] [Related]
11. Endothelial-to-Mesenchymal Transition: Potential Target of Doxorubicin-Induced Cardiotoxicity.
Feng J; Wu Y
Am J Cardiovasc Drugs; 2023 May; 23(3):231-246. PubMed ID: 36841924
[TBL] [Abstract][Full Text] [Related]
12. ConjuPepDB: a database of peptide-drug conjugates.
Balogh B; Ivánczi M; Nizami B; Beke-Somfai T; Mándity IM
Nucleic Acids Res; 2021 Jan; 49(D1):D1102-D1112. PubMed ID: 33125057
[TBL] [Abstract][Full Text] [Related]
13. Drug targeting to decrease cardiotoxicity - determination of the cytotoxic effect of GnRH-based conjugates containing doxorubicin, daunorubicin and methotrexate on human cardiomyocytes and endothelial cells.
Polgár L; Lajkó E; Soós P; Láng O; Manea M; Merkely B; Mező G; Kőhidai L
Beilstein J Org Chem; 2018; 14():1583-1594. PubMed ID: 30013686
[No Abstract] [Full Text] [Related]
14. Comparative cell biological study of in vitro antitumor and antimetastatic activity on melanoma cells of GnRH-III-containing conjugates modified with short-chain fatty acids.
Lajkó E; Spring S; Hegedüs R; Biri-Kovács B; Ingebrandt S; Mező G; Kőhidai L
Beilstein J Org Chem; 2018; 14():2495-2509. PubMed ID: 30344773
[No Abstract] [Full Text] [Related]
15. Improved In Vivo Anti-Tumor and Anti-Metastatic Effect of GnRH-III-Daunorubicin Analogs on Colorectal and Breast Carcinoma Bearing Mice.
Ranđelović I; Schuster S; Kapuvári B; Fossati G; Steinkühler C; Mező G; Tóvári J
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31557968
[TBL] [Abstract][Full Text] [Related]
16. Apoptotic Effects of Drug Targeting Conjugates Containing Different GnRH Analogs on Colon Carcinoma Cells.
Lajkó E; Hegedüs R; Mező G; Kőhidai L
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31500399
[TBL] [Abstract][Full Text] [Related]
17. AEZS-108 : a targeted cytotoxic analog of LHRH for the treatment of cancers positive for LHRH receptors.
Engel J; Emons G; Pinski J; Schally AV
Expert Opin Investig Drugs; 2012 Jun; 21(6):891-9. PubMed ID: 22577891
[TBL] [Abstract][Full Text] [Related]
18. Cancer chemotherapy based on targeting of cytotoxic peptide conjugates to their receptors on tumors.
Schally AV; Nagy A
Eur J Endocrinol; 1999 Jul; 141(1):1-14. PubMed ID: 10407215
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
